Location History:
- Ahmedabad, IN (2013)
- Gujarat, IN (2015 - 2019)
Company Filing History:
Years Active: 2013-2019
Title: Innovations and Contributions of Himanshu M Kothari
Introduction
Himanshu M Kothari is a notable inventor based in Gujarat, India. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of diabetes and lipodystrophy. With a total of seven patents to his name, Kothari's work reflects a commitment to advancing medical science and improving patient outcomes.
Latest Patents
Kothari's latest patents include a synergistic composition aimed at treating diabetes, specifically non-insulin dependent diabetes (NIDDM) or Type 2 diabetes. This invention describes a composition that combines one or more statins, dipeptidyl peptidase IV (DPP IV) inhibitors, biguanide antihyperglycaemic agents, and a PPAR agonist. The invention also details the preparation of these compositions and novel salts of the PPAR agonist, along with their applications in treating diabetes-related conditions. Another significant patent focuses on a therapeutic compound for the prevention and treatment of lipodystrophy caused by HIV infection. This compound aims to neutralize lipohypertrophy, lipoatrophy, and metabolic abnormalities in HIV patients.
Career Highlights
Himanshu M Kothari is currently associated with Cadila Healthcare Limited, a prominent player in the pharmaceutical industry. His work at Cadila has allowed him to explore innovative solutions to complex health issues, contributing to the company's reputation for excellence in research and development.
Collaborations
Kothari has collaborated with notable colleagues such as Bipin Pandey and Mukul R Jain. These collaborations have fostered a productive environment for innovation and have led to the development of impactful medical solutions.
Conclusion
Himanshu M Kothari's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his dedication to improving healthcare. His innovative approaches to treating diabetes and lipodystrophy demonstrate the potential for scientific advancements to enhance patient care.